Clinical Report: Mistakes Identified in Figure Legends
Overview
Errors were identified in the figure legends of a recent investigation on RSV prevention products. The labels for age groups were transposed, necessitating a correction to the published article.
Background
Accurate figure legends are crucial for the interpretation of clinical research findings. This report highlights the importance of meticulous review processes in scientific publications.
Data Highlights
No numerical or trial data is presented in the source material.
Key Findings
- Errors in the figure keys of Figures 1 and 3 were identified in the RSV prevention study.
- The age labels for 7 months or younger and 8 to 24 months were transposed.
- Corrections have been made to the article to rectify these errors.
- Incorrect references were cited in the legends of Figures 3 and 4 in related articles.
- Figure legends must be accurate to ensure proper understanding of research data.
Clinical Implications
Healthcare professionals should be aware of the potential for errors in published research.
Related Resources & Content
- CDC, RSV Immunization Guidance for Infants and Young Children, 2026 -- RSV Immunization Guidance for Infants and Young Children
- FDA, Drug Trials Snapshots: ENFLONSIA, 2025 -- Drug Trials Snapshots: ENFLONSIA
- American Academy of Pediatrics, Effectiveness of RSV Prevention Strategies in US Infants, 2026 -- Effectiveness of RSV Prevention Strategies in US Infants
- European Radiology — Reevaluation of a Decade of Gadolinium Retention and Deposition: Insights from ESMRMB-GREC
- Bone Marrow Transplantation — Correction: Graft-versus-Leukemia Effects in T-Prolymphocytic Leukemia: Insights from MRD Dynamics and TCR Repertoire Assessments
- Erratum: 3D Reconstruction from Microscopic Imaging for Computer-Assisted Eye Surgery
- Journal of Neuro-Oncology (Springer) — Erratum: Evaluating Phosphoenolpyruvate Carboxykinase 2 as a Prognostic Indicator: Its Expression and Clinical Relevance in Group 3 and Group 4 Medulloblastoma
- RSV Immunization Guidance for Infants and Young Children | RSV | CDC
- Drug Trials Snapshots: ENFLONSIA | FDA
- Effectiveness of RSV Prevention Strategies in US Infants: 2024–2025 | Pediatrics | American Academy of Pediatrics
Based on findings from:
Errors in Figure Keys
Jama Network Open, 2026.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2853924
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
